Indonesia grants emergency use authorization to Sinovac’s COVID-19 vaccine

Health workers check the boxes containing coronavirus vaccines developed by China’s Sinovac Biotech as they arrived in Bali, Indonesia on Thursday, Jan. 7, 2021. (AP)

• Interim data from a late-stage human test in Indonesia showed the shot was 65.3% effective

JAKARTA: Indonesia’s food and drug agency on Monday granted emergency use approval to a COVID-19 vaccine developed by China’s Sinovac Biotech, as it became the first country outside China to give the regulatory greenlight to the vaccine.
Interim data from a late-stage human test in Indonesia showed the shot was 65.3% effective, Penny K. Lukito, who heads the country’s food and drugs authority BPOM said.